First US Surgeries Performed Using ZIP ULTRA™
Aurora Spine Corporation (TSX VENTURE:ASG) announced today that the first U.S. surgical implant of the company's ZIP ULTRA™ Minimally Invasive Interspinous Fusion System was performed at Southern California Hospital in Culver City, CA. The ZIP ULTRA provides surgeons with a greater ability to treat a wide range of spinal pathologies, all while being easy to use. Surgeons have started to schedule surgeries now that the system is available for sale and use in the United States.
The initial U.S. procedure was performed by Dr. Ian Armstrong, a specialist in neurosurgery, microsurgery and spinal instrumentation. Dr. Armstrong is the Medical Director of the Southern California Spine Institute, a premier center for the treatment of spinal disorders.
"The ZIP ULTRA MIS Interspinous Fusion System is elegant and well designed for minimally invasive surgery. It grants greater flexibility during procedures, forcing me to re-evaluate how spine surgery should be performed in the future," stated Dr. Armstrong. "Safety is a very important factor to me and I was happy to see reduced radiation exposure during the ZIP ULTRA procedure. The strength of the implant allows it to be used in place of pedicle screws when applicable. I strongly believe the ZIP implant is a game changer."
In late November Aurora launched its FDA 510(k) cleared AURORA DISCOVERY™ Interbody system. DISCOVERY is a cervical intervertebral body fusion device consisting of teeth on the inferior and superior surfaces to prevent back out and migration. The implant design is rectangular with a hollow core for bone graft to promote integration and fusion between the endplates. The first surgical implant of the AURORA DISCOVERY Interbody System was performed on November 26, 2013.
"These two surgeries are huge milestones that we believe will establish Aurora as the leader in advanced spinal technologies" stated Trent Northcutt, President and CEO of Aurora Spine. "We are extremely excited about the continuous growth and progress the company is making. Aurora Spine will continue to develop products that are truly minimally invasive technologies."
About Aurora Spine
Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies.
This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the growth potential of the Aurora Spine's products. Aurora Spine cautions investors of Aurora Spine's securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.
For more information, please contact:
Aurora Spine Corporation
President and Chief Executive Officer
Chief Financial Officer